Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.55% | 81.96% | -427.32% | 45.32% | 2.33% |
| Total Depreciation and Amortization | 90.59% | -47.26% | -0.51% | -35.16% | 53.27% |
| Total Amortization of Deferred Charges | -232.06% | -43.05% | -32.04% | 326.89% | -200.00% |
| Total Other Non-Cash Items | -72.23% | -97.90% | 1,280.20% | -258.22% | 78.33% |
| Change in Net Operating Assets | 196.85% | -237.48% | 313.65% | 220.94% | -75.65% |
| Cash from Operations | 22.18% | -89.55% | 43.56% | 21.33% | 4.47% |
| Capital Expenditure | 66.67% | -- | 100.00% | 75.34% | 75.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -99.29% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.67% | -- | 100.00% | 74.94% | 47.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -200.00% | -- | -- |
| Issuance of Common Stock | 94.46% | 268.73% | 53,960.87% | -99.79% | 59.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -47.27% | 52.42% | -- | -- | 2,942.29% |
| Cash from Financing | 98.47% | 510.75% | 3,413.68% | -100.52% | 548.93% |
| Foreign Exchange rate Adjustments | 241.18% | -1,800.00% | 125.00% | 60.00% | 16.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.99% | 932.28% | 83.84% | -199.81% | 199.94% |